11:16 AM EST, 12/02/2024 (MT Newswires) -- European equities traded in the US as American depositary receipts kicked off the week trending lower late Monday morning, declining 0.37% to 1,326.63 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by semiconductor company Sequans Communications ( SQNS ) and pharmaceutical company Novo Nordisk ( NVO ) , which rose 11% and 1.8% respectively. They were followed by internet browser company Opera (OPRA) and telecommunications company Ericsson (ERIC), which were up 1.7% and 0.5% respectively.

The decliners from continental Europe were led by biopharmaceutical company Genfit ( GNFT ) and furniture maker Natuzzi (NTZ), which lost 5.4% and 3.4% respectively. They were followed by biotech firm Evaxion Biotech ( EVAX ) and oil and gas company TotalEnergies (TTE), which dropped 3% and 2.6% respectively.

From the UK and Ireland, the gainers were led by pharmaceutical company Silence Therapeutics ( SLN ) and cruise line operator Carnival (CUK), which were up 6.5% and 3.1% respectively. They were followed by biopharmaceutical companies Verona Pharma ( VRNA ) and Mereo BioPharma Group (MREO), which rose 0.6% each.

The decliners from the UK and Ireland were led by biotech firm Trinity Biotech ( TRIB ) and biopharmaceutical company TC Biopharm ( TCBP ) , which dropped 4.5% and 4.2% respectively. They were followed by biopharmaceutical company Akari Therapeutics ( AKTX ) and oil and gas company BP (BP), which were off 2.6% and 2.1% respectively.